Thrivent Financial For Lutherans Roivant Sciences Ltd. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 123,823 shares of ROIV stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,823
Previous 186,051
33.45%
Holding current value
$1.32 Million
Previous $1.97 Million
27.31%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$701 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$699 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$575 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$443 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$376 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.49B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...